Literature DB >> 16858027

NICE hears appeals over dementia drugs.

Zosia Kmietowicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16858027      PMCID： PMC1513446          DOI： 10.1136/bmj.333.7560.165

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Societal values in the allocation of healthcare resources: is it all about the health gain?

Authors:  Tania Stafinski; Devidas Menon; Deborah Marshall; Timothy Caulfield
Journal:  Patient       Date:  2011       Impact factor: 3.883

2.  What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink.

Authors:  Venexia M Walker; Neil M Davies; Patrick G Kehoe; Richard M Martin
Journal:  Alzheimers Res Ther       Date:  2018-05-29       Impact factor: 6.982

3.  Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.

Authors:  Hirohisa Imai; Takuya Hirai; Ryosuke Kumazawa; Shunsaku Nakagawa; Atsushi Yonezawa; Kazuo Matsubara; Hiroyuki Nakao
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.